Feasibility and acceptability of GeneXpert MTB/XDR implementation among healthcare workers in three low-middle income African countries.
<h4>Background</h4>Xpert MTB/XDR (Xpert-XDR) testing can significantly shorten time to initiating appropriate drug-resistant tuberculosis (DR-TB) treatment, but its introduction may impact laboratory workflow, especially in laboratories not currently performing drug susceptibility testin...
Saved in:
| Main Authors: | Sara Keller, Kogieleum Naidoo, Medhane Zekarias, Sussan Israel-Isah, Mohammed Shaka, Gcinile Gule, Anushka Naidoo, Miriam Bathnna, Judith Nomthandazo Dlamini-Miti, Kalkidan Yae, Evaezi Okpokoro, Alash'le Abimiku, Ahmed Bedru, Edine W Tiemersma, TRiAD Study Consortium |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0326342 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mycobacterium tuberculosis Detection in Diverse Clinical Specimens by GeneXpert MTB/RIF: A Large-Scale Retrospective Study
by: Li H, et al.
Published: (2025-05-01) -
Taking XDR TB seriously in South Africa
by: Natasha Bolognesi, et al.
Published: (2007-12-01) -
Change in TB diagnostic profile after introduction of GeneXpert MTB/RIF assay in National TB Program of Armenia, 2013-2017
by: Eduard Kabasakalyan, et al.
Published: (2019-05-01) -
XDR TB in South Africa - What lies ahead?
by: V. Thaver, et al.
Published: (2007-12-01) -
XDR typhoid in Pakistan: A threat to global health security and a wake-up call for antimicrobial stewardship.
by: Muhammad Ahmed Abdullah, et al.
Published: (2025-05-01)